Siemens Healthineers has agreed to acquire Corindus Vascular Robotics for approximately $1.1 billion, with the deal expected to go through before the end of the year.
Bill Truslow ©2016 Bill Truslow
Surgeon at Core Path Console w/Patient
Surgeon at Core Path Console w/Patient
Corindus develops, produces and sells robotic systems for minimally invasive procedures. These systems help doctors to control guide catheters, guide wires, balloon or stent implants via integrated imaging.
Corindus offers a robotic treatment platform for major vascular therapeutic markets, meaning coronary, peripheral vascular and neurovascular interventions.
Bernd Montag, CEO of Siemens Healthineers, said: "Together with Corindus, Siemens Healthineers is well-positioned to be one of the leading players in the field of robotic vascular interventions and to perform minimally invasive procedures more accurately, more quickly and more effectively. With this acquisition, we are opening up a new field for our image-guided therapies business. Together with our strong portfolio in imaging, digitalisation and artificial intelligence, we are creating significant synergies to advance therapy outcomes.”
The acquisition of Corindus meets the objective of simplifying today's challenges in everyday hospital life. Robotic assisted minimally invasive procedures have the potential to reduce treatment times, increase precision during treatment, raise standardization levels in clinical procedures and ultimately improve clinical outcomes, which is the strategic focus of the Advanced Therapies business segment.
Mark Toland, president and CEO at Corindus, said: "The collaboration with Siemens Healthineers is a unique opportunity to take our business to the next level and continue our success story. Together we plan to develop next-generation solutions that further improve patient care.”
The CorPath systems developed by Corindus will be used together with angiography systems that Siemens Healthineers sells as one of the leading suppliers. The Siemens Healthineers products make minimally invasive treatment possible by using imaging before and during medical interventions.
The aim of integration of Siemens’ digitisation and AI solutions with Corindus robotic systems is to further increase procedure optimisation in order to enable the greatest possible degree of efficiency and clinical reproducibility.
